LIM
ALXN

Lagoda Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Lagoda Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,000
Closed -$120K – 43
2017
Q4 		$120K Sell
1,000
-7,905
-89% -$963K 0.05% 30
2017
Q3 		$1.25M Sell
8,905
-2,200
-20% -$299K 0.45% 22
2017
Q2 		$1.35M Sell
11,105
-106,840
-91% -$12.4M 0.52% 21
2017
Q1 		$14.3M Sell
117,945
-43,257
-27% -$5.58M 5.55% 9
2016
Q4 		$19.7M Buy
161,202
+3,349
+2% +$410K 6.77% 7
2016
Q3 		$19.3M Buy
157,853
+293
+0.2% +$37.7K 5.82% 9
2016
Q2 		$18.4M Sell
157,560
-1,922
-1% -$273K 6.86% 8
2016
Q1 		$22.2M Sell
159,482
-5,527
-3% -$812K 7.27% 4
2015
Q4 		$31.5M Sell
165,009
-1,905
-1% -$333K 8.34% 3
2015
Q3 		$26.1M Buy
166,914
+3,528
+2% +$644K 7.62% 3
2015
Q2 		$29.5M Buy
163,386
+8,923
+6% +$1.54M 7.74% 4
2015
Q1 		$26.8M Sell
154,463
-46,002
-23% -$8.33M 7.16% 3
2014
Q4 		$37.1M Buy
+200,465
New +$37.1M 9.9% 2

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lagoda Investment Management's ALXN Position: Q1 2018 in Review

Lagoda Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q1 2018, closing a stake of 1,000 shares — an estimated $120K sold.

Lagoda Investment Management first reported a position in ALXN in Q4 2014 and held it in 13 quarters. The position peaked at $37.1M in Q4 2014. 597 funds tracked by Wall St. Rank hold ALXN as of Q1 2018.

  • Lagoda Investment Management reported no remaining Alexion Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Lagoda Investment Management sold 1,000 Alexion Pharmaceuticals shares in Q1 2018, an estimated $120K.
  • Lagoda Investment Management first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 13 quarters.
  • Lagoda Investment Management's Alexion Pharmaceuticals position peaked at $37.1M in Q4 2014.
  • 597 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2018.

Based on Lagoda Investment Management's 13F filing for Q1 2018, filed 15 May 2018.